{
  "ptid_time": "041_S_6159_2020-01-09",
  "img_path": "/data/qiuhui/data/adni/images/041_S_6159/2020-01-09/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 65,752 mm³, 70.7% above the reference mean. With a Z-score of 1.69 (95.5th percentile), this represents moderate enlargement; hippocampal volume measures 6,161 mm³, 18.5% below the reference mean. With a Z-score of -1.80 (3.6th percentile), this represents moderate atrophy; whole brain volume measures 1,114,530 mm³, 3.3% above the reference mean. With a Z-score of 0.42 (66.4th percentile), this represents normal volume ; entorhinal cortex volume measures 3,402 mm³, 17.0% below the reference mean. With a Z-score of -1.16 (12.4th percentile), this represents mild atrophy; fusiform gyrus volume measures 17,649 mm³, 6.3% below the reference mean. With a Z-score of -0.54 (29.5th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,184 mm³, 4.0% above the reference mean. With a Z-score of 0.36 (63.9th percentile), this represents normal volume . ",
  "text_data": "Age is 78.2 years. Gender is Male. Education: 20 years. MMSE: 30.0. MoCA: 28.0. Logical Memory: 12.0. APOEε4 alleles: 0.0. Biomarker levels: Flobetaben (FBB): 1.05 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "Reasoning: The imaging data shows moderate hippocampal and mild entorhinal cortex atrophy, which are hallmark features of Alzheimer's disease (AD), along with moderate ventricular enlargement (a marker of brain atrophy). However, cognitive scores (MMSE 30, MoCA 28) are intact, and there is no APOE4 risk allele.  \nDiagnosis: **Mild Cognitive Impairment (MCI)** (likely prodromal AD given hippocampal atrophy, but cognition is preserved)  \nConfidence: **Medium** (high confidence in structural changes, but cognitive scores complicate the diagnosis)",
  "timestamp": "2025-07-26T07:28:57.195937"
}